TAVR and Valve-in-Valve (Michael Reardon, MD)
Faculty Interview with Dr. Michael Reardon | CardioVascular Interventions Summit 2024Подробнее
Medtronic Tavr | Dr. Michael Reardon | Daily FlashПодробнее
Breaking News: Medtronic TAVR Low-Risk Clinical Trial Results Released!Подробнее
Michael Reardon: TMVR (Medtronic Apollo Trial)Подробнее
Michael J Reardon, MD - TAVR in Asymptomatic or Moderate ASПодробнее
1.26.23 Grand Rounds: TAVR and the Lifetime Management of Aortic Stenosis: TAVR and the Lifetime ...Подробнее
Michael J Reardon, MD on durability of TAVR in patients with aortic stenosis with Chadi Alraies, MDПодробнее
Lifetime Management of Aortic Stenosis (Kendra J Grubb, MD, Michael Reardon, MD)Подробнее
View the New Generation Navitor Vision* ValveПодробнее
Lifetime Management of Aortic Stenosis (Kendra J. Grubb, MD, Michael Reardon, MD)Подробнее
Redo-Aortic Valve Replaced–Annular Enlargement Y Incision & Rectangle Patch (Reardon MD, Al Abri MD)Подробнее
Low Risk TAVR: What the Data Tells Us (Michael J. Reardon, MD) March 26, 2020Подробнее
Disruptive Innovation: TAVR 20 Years Later | April 4Подробнее
Which Low-Risk Patients Should Receive TAVR?Подробнее
Aortic InnovationsПодробнее
How Innovation Happens: Lessons from the Transcatheter Valve Trials (Michael Mack, MD) Nov. 14, 2019Подробнее
Next generation TAVR device will enable lifetime management of AS patients - EuroPCR 2021Подробнее
TAVR Explantation Due to Late Thrombosis Leading to Cardiogenic Shock (M Reardon, S Goel, Q Al Abri)Подробнее
TAVR Explantation, Root Enlargement, Aortic Valve Replacement(Wv Ballmoos MD; Reardon MD; Zubair MD)Подробнее
Transcatheter Aortic Valve Explantation – Surgical Aortic Valve Replacement (Wyler von Ballmoos, MD)Подробнее